After a Year of 0.6% Returns, Iovance Biotherapeutics, Inc.'s (NASDAQ:IOVA) Share Price Drop Last Week May Have Less of an Impact on Institutional Investors

Simply Wall StDec 15 09:31 ET

Peering Into Iovance Biotherapeutics's Recent Short Interest

BenzingaDec 5 12:45 ET

Is Iovance Biotherapeutics Stock a Millionaire Maker?

Yahoo FinanceNov 27 06:30 ET

Press Release: Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer

Dow JonesNov 26 16:01 ET

Express News | Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.d., Ph.d. to Chief Regulatory Officer

ReutersNov 26 16:01 ET

Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer

Iovance BiotherapeuticsNov 26 00:00 ET